Coding the Impossible Cure The First AI-Powered Drug with Safety and Efficacy Proved in Phase IIa @InsilicoMedicine
Coding the Impossible Cure The First AI-Powered Drug with Safety and Efficacy Proved in Phase IIa @InsilicoMedicine
Uploaded January 2025 | Updated September 2026, 2 weeks ago
As our IPF program reaches a new clinical milestone, we're excited to update our documentary and share the joy and confidence in AI-driven drug discovery with you. In November 2024, Insilico announced positive topline data from the IPF Phase IIa study. The results demonstrate that our drug, ISM001-055, exhibits a strong safety profile and dose-dependent efficacy. This achievement marks a significant milestone in the AI-powered drug discovery world, as ISM001-055 was developed using our proprietary end-to-end AI platform, Pharma.AI.
Coding the Impossible Cure The First AI-Powered Drug with Safety and Efficacy Proved in Phase IIaHow to measure the R&D productivity of an AI-powered drug discovery algorithm or company?DISCOVERY OF 3CL PROTEASE INHIBITOR by Dr Michael LevittTarget ID and Target Validation in PandaOmics 2.0A major update on ISM9528NVIDIA GTC Conference VideoInsilico Medicine at BIO 2022A Call for Longevity CollaborationLiquid AI x Insilico Launch LFM2-2.6B-MMAI (Live Demo)Longevity Lobster VS Longevity ClawInsilico Medicine Boston Office LaunchA Deep Dive into AI-Driven Longevity with Precious3GPT and Python
Insilico Medicine |

Coding the Impossible Cure--The First AI-Powered Drug with Safety and Efficacy Proved in Phase IIa

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER